메뉴 건너뛰기




Volumn 13, Issue 4, 2003, Pages 367-

Drug distribution and expenditure: The issue of Epoetin in Italy

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; RECOMBINANT ERYTHROPOIETIN;

EID: 0347355040     PISSN: 11011262     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurpub/13.4.367     Document Type: Note
Times cited : (5)

References (7)
  • 1
    • 0022258403 scopus 로고
    • Anemia of end-stage renal disease (ESRD)
    • Eschbach JW, Adamson JW. Anemia of end-stage renal disease (ESRD). Kidney Int 1985;28:1-5.
    • (1985) Kidney Int , vol.28 , pp. 1-5
    • Eschbach, J.W.1    Adamson, J.W.2
  • 2
    • 0036787775 scopus 로고    scopus 로고
    • Use of Epoetin in patients with cancer: Evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology
    • Rizzo JD, Lichtin AE, Woolf SH, et al. Use of Epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. J Clin Oncol 2002;20:4083-107.
    • (2002) J Clin Oncol , vol.20 , pp. 4083-4107
    • Rizzo, J.D.1    Lichtin, A.E.2    Woolf, S.H.3
  • 3
    • 1242288595 scopus 로고    scopus 로고
    • Anno 2001. Ministero della Salute. Direzione Generale della Valutazione dei Medicinali e della Farmacovigilanza. Roma (Italy): Istituto Poligrafico e Zecca dello Stato - S.
    • Addis A, Brunetti M, Caffari B, et al. L'uso dei farmaci in Italia. Rapporto Nazionale [The use of drugs in Italy. National Report]. Anno 2001. Ministero della Salute. Direzione Generale della Valutazione dei Medicinali e della Farmacovigilanza. Roma (Italy): Istituto Poligrafico e Zecca dello Stato - S.; 2002.
    • (2002) L'uso dei Farmaci in Italia. Rapporto Nazionale [The Use of Drugs in Italy. National Report]
    • Addis, A.1    Brunetti, M.2    Caffari, B.3
  • 4
  • 5
    • 0035210976 scopus 로고    scopus 로고
    • Cancer-related anaemia requires higher doses of epoetin alfa than chronic renal failure replacement therapy
    • Itri LM. Cancer-related anaemia requires higher doses of epoetin alfa than chronic renal failure replacement therapy. Nephrol Dial Transplant 2001;16:2289-93.
    • (2001) Nephrol Dial Transplant , vol.16 , pp. 2289-2293
    • Itri, L.M.1
  • 6
    • 0035880780 scopus 로고    scopus 로고
    • Epoetin treatment of anemia associated with cancer therapy: A systematic review and meta-analysis of controlled clinical trials
    • Seidenfeld J, Piper M, Flamm C, et al. Epoetin treatment of anemia associated with cancer therapy: a systematic review and meta-analysis of controlled clinical trials. J Natl Cancer Inst 2001;93:1204-14.
    • (2001) J Natl Cancer Inst , vol.93 , pp. 1204-1214
    • Seidenfeld, J.1    Piper, M.2    Flamm, C.3
  • 7
    • 85112388440 scopus 로고    scopus 로고
    • Epoetin alfa practice pattern usage in community practice sites
    • Lawless G, Wilson-Royalty M, Meyers J. Epoetin alfa practice pattern usage in community practice sites. Blood 2000;96:390b.
    • (2000) Blood , vol.96
    • Lawless, G.1    Wilson-Royalty, M.2    Meyers, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.